Publications

5674 Results

Evaluation of Activation of a National Cancer Trials Network (NCTN) trial for Hodgkin Lymphoma (HL) at Children’s Oncology Group (COG) Institutions

Authors
S Castellino;A Punnett;S Parsons;N Degroote;S Muehle;M Roth;A Herrera;JW Friedberg;N Siebel;K Kelly
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S1826

PHASE III STUDY OF DARATUMUMAB/rHuPH20 (NSC- 810307) + LENALIDOMIDE OR LENALIDOMIDE AS POST-AUTOLOGOUS STEM CELL TRANSPLANT MAINTENANCE THERAPY IN PATIENTS WITH MULTIPLE MYELOMA (MM) USING MINIMAL RESIDUAL DISEASE TO DIRECT THERAPY DURATION (DRAMMATIC STUDY): SWOG S1803

Authors
A Krishnan;A Hoering;P Hari;R Sexton;R Orlowski
Journal / Conference
American Society of Hematology (December 5-8, 2020, San Diego, CA), TIPs, poster presentation
Year
2020
Research Committee(s)
Myeloma
Study Number(s)
S1803

Emerging from COVID-19 pandemic: provider perspective on use of neoadjuvant endocrine therapy (NETI in early stage hormone receptor positive breast cancer

Authors
KU Park;M Gregory;M Lustberg;J Bazan;C Shen;S Rosenberg;V Blinder;P Sharma;L Pusztai;A Partridge;A Thompson
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), COVID-19 Session, abst. SS2-05, poster
Year
2020
Research Committee(s)
Breast

Successful implementation of a novel trial design in a palliative care population

Authors
K Arnold;G Anderson;J Deneve;R Topacio;R Krouse
Journal / Conference
Society for Clinical Trials (virtual meeting September 1, 2020 - April 30, 2021), poster
Year
2020
Research Committee(s)
Palliative Care
Study Number(s)
S1316

New strategies to improve drug development in carcinoid tumors (Alliance A021202)

Authors
E Bergsland;S Geyer;M Mahoney;T Asmis;N Hall;S Karovic;M Knopp;P Kumthekar;A Nixon;E OReilly;L Schwartz;J Strosberg;J Meyerhardt;M Maitland
Journal / Conference
Neuroendocrine Tumor Research Foundation Research Symposium (November 2020), poster
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021202

Female sex is a potential independent predictor of adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition

Authors
A Tarhini;S Lee;S Hodi;U Rao;G Cohen;O Hamid;L Hutchins;J Sosman;H Kluger;Z Eroglu;H Koon;D Lawrence;K Kendra;D Minor;C Lee;M Albertini;L Flaherty;T Petrella;H Streicher;V Sondak;J Kirkwood
Journal / Conference
Society for Immunotherapy of Cancer (SITC) Annual Meeting (November 10-15, 2020, virtual), poster
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Authors
A Brandao;P Paulo;S Maia;M Pinheiro;A Peixoto;M Cardoso;C Tangen;D Albanes;M Roobol;Profile Study Steering Cmte;PRACTICAL Consortium;M Teixeira
Journal / Conference
Cancers (Basel) Nov 4;12(11):3254. doi: 10.3390/cancers12113254
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33158149
PMC
PMC7694218
Study Number(s)
S0000, SWOG-9217

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

Authors
T Andre;J Meyerhardt;T Iveson;A Sobrero;T Yoshino;I Souglakos;D Niedzwiecki;M Saunders;R Labianca;T Yamanaka;I Boukovinas;D Vernerey;J Meyers;A Harkin;V Torri;E Georgoulias;E Oki;J Taieb;AF Shields;Q Shi
Journal / Conference
Lancet Oncology Dec;21(12):1620-1629. doi: 10.1016/S1470-2045(20)30527-1.
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID33271092
PMC
PMC7786835
Study Number(s)
CTSU/C80702

Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

Authors
C Bull;J Bell;N Murphy;E Sanderson;G Smith;N Timpson;D Albanes;E Platz;C Tangen;A Wu;P Campbell;W Zheng;U Peters;E Vincent;M Gunter
Journal / Conference
BMC Medicine Dec 17;18(1):396
Year
2020
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33327948
PMC
PMC7745469
Study Number(s)
S0000

Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials

Authors
M Sedrak;C-L Sun;D Hershman;J Unger;J Liu;W Dale;D Dizon
Journal / Conference
JAMA Network Open Dec 1;3(12):e2031202
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
PMID33369658
PMC
PMC7770556